A silent killer: Cytomegalovirus infection in the nonimmunocompromised critically ill patient

Critical Care Medicine

Volumn 36, Issue 12, 2008, Pages 3261-3264

  Kalil, Andre C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus; Intensive care unit; Severe sepsis

Indexed keywords

ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS INFECTION; EDITORIAL; GRAFT RECIPIENT; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; IMMUNOCOMPETENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER DYSFUNCTION; MORTALITY; NATURAL KILLER CELL; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; VIREMIA; CRITICAL ILLNESS; IMMUNOLOGY; NOTE; PREVALENCE;

CRITICAL ILLNESS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; SEPSIS;

EID: 58149217137     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31818f24c3     Document Type: Editorial

References (38)

1. Stanberry LR, Rosenthal SL, Mills L, et al: Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalo-virus infections among young adolescent girls. Clin Infect Dis 2004; 39:1433-1438
2. Sester M, Sester U, Gartner BC, et al: Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J Am Soc Nephrol 2002; 13:2577-2584
3. Gandhi MK, Khanna R: Human cytomegalo-virus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004; 4:725-738
4. Kalil AC, Levitsky J, Lyden E, et al: Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143:870-880
5. Boeckh M, Nichols WG, Papanicolaou G, et al: Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003; 9:543-558
6. Steininger C, Puchhammer-Stockl E, Popow-Kraupp T: Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol 2006; 37:1-9
7. Boeckh M, Nichols WG: Immunosuppressive effects of beta-herpesviruses. Herpes 2003; 10:12-16
8. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
9. Bone RC: Sir isaac newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128
10. Docke WD, Prosch S, Fietze E, et al: Cyto-megalovirus reactivation and tumor necrosis factor. Lancet 1994; 343:268-269
11. Kutza AS, Muhl E, Hackstein H, et al: High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998; 26:1076-1082
12. Cook CH, Trgovcich J, Zimmerman PD, et al: Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immuno-competent mice. J Virol 2006; 80:9151-9158
13. Prosch S, Wendt CE, Reinke P, et al: A novel link between stress and human cytomegalo-virus (HCMV) infection: Sympathetic hyper-activity stimulates HCMV activation. Virology 2000; 272:357-365
14. Bruggeman CA, Debie WH, Muller AD, et al: Cytomegalovirus alters the von willebrand factor content in human endothelial cells. Thromb Haemost 1988; 59:264-268
15. Sutherland MR, Raynor CM, Leenknegt H, et al: Coagulation initiated on herpesvi-ruses. Proc Natl Acad Sci USA 1997; 94: 13510-13514
16. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
17. Cook CH, Zhang Y, McGuinness BJ, et al: Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 2002; 185:1395-1400
18. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al: Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review. Virol J 2008; 5:47
19. Stephan F, Meharzi D, Ricci S, et al: Evaluation by polymerase chain reaction of cyto-megalovirus reactivation in intensive care patients under mechanical ventilation. Intensive Care Med 1996; 22:1244-1249
20. Cook CH, Martin LC, Yenchar JK, et al: Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003; 31:1923-1929
21. Desachy A, Ranger-Rogez S, Francois B, et al: Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 2001; 32:197-203
22. Razonable RR, Fanning C, Brown RA, et al: Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immuno-competent hosts. J Infect Dis 2002; 185: 110-113
23. Heininger A, Jahn G, Engel C, et al: Human cytomegalovirus infections in nonimmuno-suppressed critically ill patients. Crit Care Med 2001; 29:541-547
24. von Muller L, Klemm A, Weiss M, et al: Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006; 12: 1517-1522
25. Domart Y, Trouillet JL, Fagon JY, et al: Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 1990; 97:18-22
26. Cook CH, Yenchar JK, Kraner TO, et al: Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998; 176:357-360
27. Jaber S, Chanques G, Borry J, et al: Cytomeg-alovirus infection in critically ill patients: Associated factors and consequences. Chest 2005; 127:233-241
28. Papazian L, Fraisse A, Garbe L, et al: Cyto-megalovirus: An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280-287
29. Troselj-Vukic B, Milotic I, Milotic F, et al: Cytomegalovirus reactivation after low-dose steroid treatment for hemolytic anemia in a patient with primary epstein-barr virus infection. Wien Klin Wochenschr 2007; 119: 435-437
30. Aukrust P, Moum B, Farstad IN, et al: Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis 1991; 23:495-499
31. Clerc D, Brousse C, Mariette X, et al: Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone. Ann Rheum Dis 1991; 50:67
32. Lin TY, Ni YH, Chang FY, et al: Cytomegalovirus pneumonitis in a patient with nephrotic syndrome receiving low-dose prednisolone and pulmonary tuberculosis. Am J Med Sci 2007; 334:393-395
33. Ho M: Cytomegalovirus infection in patients with bacterial sepsis. Clin Infect Dis 1998; 26:1083-1084
34. Schmader KE, Rahija R, Porter KR, et al: Aging and reactivation of latent murine cytomegalovirus. J Infect Dis 1992; 166: 1403-1407
35. Mutimer D, Mirza D, Shaw J, et al: Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 1997; 63:1411-1415
36. Vamvakas EC: Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005; 19: 181-199
37. M Ziemann, Sedemund-Adib B, Reißland P, et al: Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008; 36: 3145-3150
38. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124